SHIONOGI & CO LTD (SGIOF:OTCMKTS)
$17.65 -1.258 (-6.6533%)
Analysed SHIONOGI & CO LTD (SGIOF:OTCMKTS) News Sources
Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership
25-01-2026
yahoo.com
All You Need to Know About Shionogi & Co. (SGIOY) Rating Upgrade to Buy
03-02-2026
yahoo.com
Assessing Shionogi (TSE:4507) Valuation After Strong Nine‑Month Earnings And Share Price Momentum
04-02-2026
yahoo.com
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) to Report Q1 Results: Wall Street Expects Earnings Growth
20-07-2026
yahoo.com
Shionogi Announces U.S. Government Procurement of Fetroja® (cefiderocol) Through BARDA's Project BioShield to Support National Preparedness for Drug-Resistant Bacterial Threats
28-08-2026
yahoo.com
Shionogi to Showcase Advancements Across its Infectious Disease Portfolio at IDWeek 2026
09-09-2026
yahoo.com
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates
07-05-2026
yahoo.com
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q2 Release
22-07-2026
yahoo.com
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Beats Q1 Earnings Estimates
03-08-2026
yahoo.com
What is the current price of SHIONOGI & CO LTD (SGIOF:OTCMKTS)?
The current price of SHIONOGI & CO LTD (SGIOF:OTCMKTS) is $17.65.
SHIONOGI & CO LTD (SGIOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SHIONOGI & CO LTD (SGIOF:OTCMKTS) since the previous trading day is $-1.258.
SHIONOGI & CO LTD (SGIOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SHIONOGI & CO LTD (SGIOF:OTCMKTS) since the previous trading day is -6.6533%.
What is the most recent average sentiment score for SHIONOGI & CO LTD (SGIOF:OTCMKTS)?
The most recent average sentiment score for SHIONOGI & CO LTD (SGIOF:OTCMKTS) is 46 out of 100.
What is the most recent average sentiment for SHIONOGI & CO LTD (SGIOF:OTCMKTS)?
The most recent sentiment for SHIONOGI & CO LTD (SGIOF:OTCMKTS) is .
SEC-8K** Filing Available For SHIONOGI & CO LTD (SGIOF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.